Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse
Evaluation of an Absorbable Implant for the Treatment of Nasal Valve Collapse
To evaluate the safety and feasibility of the INEX Nasal Implant in subjects with moderate to
 severe nasal valve collapse.
This study is a multicenter, nonrandomized, prospective exploratory study of the INEX Nasal
 Implant. The purpose of this study is to evaluate the safety and feasibility of the INEX
 Nasal Implant in subjects with moderate to severe nasal valve collapse.
Eligible participants are:

 1. Adult patients seeking treatment for nasal obstruction on one or both sides of the
 nose who are willing to undergo an office-based or intraoperative nasal implant
 procedure in lieu of alternative treatments (ie, surgical repair or use of an external
 dilator).

 2. Nasal valve collapse (NVC) must be a primary or significant contributor to the
 subject's nasal obstruction based on clinical presentation, physical examination and
 nasal endoscopy.

 3. Baseline Nasal Obstruction Symptom Evaluation (NOSE) score must be ≥55.

 Participants are excluded for the following:

 1. Surgical or non-surgical treatment of the nasal valve or rhinoplasty within 12 months
 before enrollment.

 2. Septoplasty, inferior turbinate reduction, or other surgical nasal procedures within 6
 months before enrollment.

 3. Recurrent nasal infections.

 4. Use of intranasal steroids within 2 weeks preimplant and 2 weeks post implantation.

 5. Presence of a permanent implant, dilator, or uses an external device in the nasal
 area.

 6. Cancerous or precancerous lesions and/or radiation exposure in the treatment area or
 chemotherapy within 24 months of the study.

 7. Significant bleeding disorders.

 8. Significant systemic diseases.

 9. Currently using nasal oxygen or continuous positive airway pressure (CPAP).